The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 216K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexander-Miller, M. A.
Right arrow Articles by Berzofsky, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexander-Miller, M. A.
Right arrow Articles by Berzofsky, J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/10/1391/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 8, October 19, 1998 1391-1399


Articles

Supraoptimal Peptide–Major Histocompatibility Complex Causes a Decrease in Bcl-2 Levels and Allows Tumor Necrosis Factor {alpha} Receptor II–mediated Apoptosis of Cytotoxic T Lymphocytes

Martha A. Alexander-Miller*, Michael A. Derby*, Apurva Sarin{ddagger}, Pierre A. Henkart{ddagger}, and Jay A. Berzofsky*

From the * Molecular Immunogenetics and Vaccine Research Section, Metabolism Branch; and the {ddagger} Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892

Cytotoxic T lymphocytes (CTLs) are primary mediators of viral clearance, but high viral burden can result in deletion of antigen-specific CTLs. We previously reported a potential mechanism for this deletion: tumor necrosis factor (TNF)-{alpha}–mediated apoptosis resulting from stimulation with supraoptimal peptide–major histocompatibility complex. Here, we show that although death is mediated by TNF-{alpha} and its receptor (TNF-RII), surprisingly neither the antigen dose dependence of TNF-{alpha} production nor that of TNF-RII expression can account for the dose dependence of apoptosis. Rather, a previously unrecognized effect of supraoptimal antigen in markedly decreasing levels of the antiapoptotic protein Bcl-2 was discovered and is likely to account for the gain in susceptibility or competence to sustain the death signal through TNF-RII. This decrease requires a signal through the TCR, not just through TNF-RII. Although death mediated by TNF-RII is not as widely studied as that mediated by TNF-RI, we show here that it is also dependent on proteolytic cleavage by caspases and triggered by a brief initial encounter with antigen. These results suggest that determinant density can regulate the immune response by altering the sensitivity of CTLs to the apoptotic effects of TNF-{alpha} by decreasing Bcl-2 levels.

Key Words: T lymphocytes, cytotoxic • apoptosis • protooncogene • proteins c-bel-2 • tumor necrosis factor


Address correspondence to Jay A. Berzofsky, Molecular Immunogenetics and Vaccine Research Section, Metabolism Branch, National Cancer Institute, Bldg. 10, Rm. 6B12, National Institutes of Health, Bethesda, MD 20892-1578. Phone: 301-496-6874; Fax: 301-496-9956; E-mail: berzofsk{at}helix.nih.gov

Martha A. Alexander-Miller's current address is Department of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1064.

Abbreviations used: AICD, activation-induced cell death; BD-FMK, Boc-Asp-fluoromethyl ketone; βZFA-FMK, CBZ-Phe-Ala-fluoromethyl ketone; TRAF, TNF receptor–associated factor.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS